Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma
Clinical trial NCT05496686 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05496686
- Sponsor
- Modulation Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-21
- Primary completion
- 2027-03-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.